Susan M. Catalano
No más puestos en curso
Fortuna: 110 $ al 31/03/2024
Perfil
Susan M.
Catalano is the founder of Cognition Therapeutics, Inc. which was founded in 2007.
She held the title of Director & Chief Scientific Officer from 2011 to 2022.
Dr. Catalano's former jobs include Director-Discovery Biology at Acumen Pharmaceuticals, Inc. and Senior Scientist at Rigel Pharmaceuticals, Inc. She earned a doctorate degree from the University of California, Irvine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
WEWORK INC. CLASS A
0.00% | 20/03/2023 | 1 472 ( 0.00% ) | 110 $ | 31/03/2024 |
Antiguos cargos conocidos de Susan M. Catalano.
| Empresas | Cargo | Fin |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Founder | 01/02/2022 |
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| ACUMEN PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Susan M. Catalano.
| University of California, Irvine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| COGNITION THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Susan M. Catalano
